Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Microphthalmia-associated transcription factor (MITF) is the principal transcription factor regulating pivotal processes in melanoma cell development, growth, survival, proliferation, differentiation and invasion. In recent years, convincing evidence has been provided attesting key roles of endolysosomal cation channels, specifically TPCs and TRPMLs, in cancer, including breast cancer, glioblastoma, bladder cancer, hepatocellular carcinoma and melanoma. In this review, we provide a gene expression profile of these channels in different types of cancers and decipher their roles, in particular the roles of two-pore channel 2 (TPC2) and TRPML1 in melanocytes and melanoma. We specifically discuss the signaling cascades regulating MITF and the relationship between endolysosomal cation channels, MAPK, canonical Wnt/GSK3 pathways and MITF.

Original publication

DOI

10.3390/biom11071021

Type

Journal article

Journal

Biomolecules

Publication Date

13/07/2021

Volume

11

Keywords

MCOLN, MITF, TFEB, TPC, TPC1, TPC2, TRPML, TRPML1, calcium, lysosome, mTOR, melanocytes, melanoma, mucolipin, two-pore, Calcium Channels, Endosomes, Gene Expression, Humans, Ion Channels, Lysosomes, Melanocytes, Melanoma, Microphthalmia-Associated Transcription Factor, Transient Receptor Potential Channels